Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2026-04
  • 2026-03
  • 2026-02
  • 2026-01
  • 2025-12
  • 2025-11
  • 2025-10
  • 2025-09
  • 2025-03
  • 2025-02
  • 2025-01
  • 2024-12
  • 2024-11
  • 2024-10
  • 2024-09
  • 2024-08
  • 2024-07
  • 2024-06
  • 2024-05
  • 2024-04
  • 2024-03
  • 2024-02
  • 2024-01
  • 2023-12
  • 2023-11
  • 2023-10
  • 2023-09
  • 2023-08
  • 2023-07
  • 2023-06
  • 2023-05
  • 2023-04
  • 2023-03
  • 2023-02
  • 2023-01
  • 2022-12
  • 2022-11
  • 2022-10
  • 2022-09
  • 2022-08
  • 2022-07
  • 2022-06
  • 2022-05
  • 2022-04
  • 2022-03
  • 2022-02
  • 2022-01
  • Palmitic acid (Hexadecanoic Acid): Technical Use & Protocols

    2026-07-19

    Palmitic acid (Hexadecanoic Acid): Technical Use & Protocols

    What This Product Solves

    Palmitic acid (hexadecanoic acid, SKU N2456) addresses the need for a high-purity, structurally confirmed saturated long-chain fatty acid in research workflows focused on metabolic disorder models, lipid metabolism, and protein palmitoylation regulation. Its defined purity (98.00%) and detailed characterization make it suitable for experiments requiring strict control over substrate composition in studies such as insulin signaling pathway analysis or inflammation signaling studies. The product’s solid form and solubility profile facilitate standardized preparation, minimizing lot-to-lot variability and supporting reproducible results. However, its hydrophobicity and solution stability constraints mean it is not appropriate for protocols dependent on aqueous solubility, nor for applications requiring long-term solution storage.

    This workflow guidance is aligned with key practical advice found in internal protocol summaries, which emphasize the importance of precise handling and immediate use for reproducibility. For extended technical background, see the protocols and technical reference detailing palmitic acid’s role in lipid metabolism and protein palmitoylation assays.

    Protocol Parameters

    • Reconstitution Solvent: Ethanol or DMSO | Solubility: ≥47.9 mg/mL (ethanol, ultrasonic assistance), ≥8.95 mg/mL (DMSO) | Applicability: For metabolic disorder and lipid metabolism pathway research | Rationale: Enables preparation of concentrated stock solutions for cell-based or biochemical assays where aqueous solubility is not required | source_type: product dossier
    • Storage Conditions: Solid at -20°C, dry and sealed | Applicability: Maintains compound stability for long-term use | Rationale: Prevents degradation and ensures consistent compound performance across experiments | source_type: product dossier
    • Solution Stability: Immediate use after reconstitution; avoid long-term storage | Applicability: For workflows in inflammation signaling studies and protein palmitoylation assays | Rationale: Solutions are prone to degradation; prompt use ensures experimental integrity | source_type: product dossier
    • Purity: 98.00% (verified by Certificate of Analysis, MS, NMR) | Applicability: For quantitative studies requiring low background interference | Rationale: High purity minimizes confounding variables in metabolic pathway assays | source_type: product dossier

    Workflow Setup and QC Checklist

    1. Verify the integrity of the Palmitic acid vial upon receipt (check for seals, desiccant, and storage temperature).
    2. Bring solid palmitic acid to room temperature in a sealed container before opening to prevent moisture uptake.
    3. Weigh the desired amount using a calibrated analytical balance; avoid static-induced loss of material.
    4. Dissolve in pre-warmed ethanol or DMSO, using ultrasonication if needed to reach full dissolution. Ensure final concentration does not exceed solubility limits (≥47.9 mg/mL for ethanol, ≥8.95 mg/mL for DMSO).
    5. Filter sterilize stock solutions if required by downstream application; use compatible filters (e.g., PTFE for organic solvents).
    6. Dispense immediately into experimental systems; avoid repeated freeze-thaw cycles and prolonged bench exposure.
    7. Document lot number, preparation date, and solvent used in lab records for traceability and reproducibility.

    Common Failure Modes and Fixes

    • Incomplete dissolution: Palmitic acid may remain undissolved if not sufficiently mixed or if solvent is too cold. Solution: Pre-warm solvent, apply gentle ultrasonication, and confirm that solubility limits are not exceeded.
    • Precipitation during experimental setup: Rapid dilution into aqueous buffers can cause precipitation. Solution: Prepare concentrated stocks in ethanol or DMSO and add dropwise to pre-warmed media with constant agitation. Consider using carrier proteins (e.g., BSA) only if validated for your assay.
    • Loss of activity or degradation: Prolonged storage of solutions at room temperature or repeated freeze-thaw cycles can reduce compound integrity. Solution: Prepare fresh solutions for each experiment and minimize storage time at non-recommended temperatures.
    • Lot-to-lot variability concerns: If variability is observed, confirm Certificate of Analysis, MS, and NMR data for each lot and standardize handling across experiments.

    Scope and Limitations

    Palmitic acid (SKU N2456) is designed for workflows investigating lipid metabolism pathway dynamics, protein palmitoylation regulation, and metabolic disorder research. It is not compatible with protocols requiring aqueous dissolution or those needing long-term solution stability. The absence of stabilizers or solubilizing agents means that users must carefully control handling to avoid precipitation and degradation. While well-suited for cell biology, signaling, and biochemical assays requiring defined lipid inputs, it should not be substituted into workflows with unknown or undefined solvent compatibility. Direct mechanistic or outcome claims should be avoided unless supported by assay-specific validation.

    Conclusion

    Palmitic acid (hexadecanoic acid, SKU N2456) provides a rigorously characterized, high-purity substrate for research in metabolic disorder models, inflammation signaling studies, and lipid metabolism pathway assays. Its solid form and defined solubility parameters support controlled experimental setup, provided that solution preparation and storage guidelines are closely followed. For further technical reference, researchers may consult the APExBIO product page. Adherence to recommended protocols is essential to maintain reproducibility and data integrity across all research applications.